why choose us

Clinical Trials Search

Showing 8,320 of 132,366 result(s)
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

Status: COMPLETED

Condition: Moderate Plaque Psoriasis

Interventions: Guselkumab will be administered as subcutaneous injection.

Date: 2023-09-09

Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

Status: COMPLETED

Condition: Psoriasis

Interventions: Active substance phospholipid esters from herring roe oil (PEHeRo)

Date: 2023-09-08

Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial

Status: COMPLETED

Condition: Obstructive Sleep Apnea

Interventions: Participants will receive customized weekly reports from the pulse oximetry data collected by the consumer wearable.

Date: 2023-09-08

Advair HFA in Healthy and HAPE Predisposed Subjects

Status: Completed

Condition: Altitude Edema

Interventions: 6 puffs (total: salmeterol 126 ug and fluticasone 270 ug) twice daily

Date: 2023-09-08

A Study of Mental Health Care in People With Cancer

Status: Completed

Condition: Breast Cancer

Interventions: Patient demographic characteristics, Clinical variables, Cornell Service Index-Short Form (CSI), Patient Health Questionnaire-9 (PHQ-9), Generalized A

Date: 2023-09-08

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Status: Completed

Condition: Delayed Gastric Emptying

Interventions: Utilize POC gastric ultrasound to identify the presence of retained gastric contents.

Date: 2023-09-08

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Status: Completed

Condition: Stress

Interventions: A 6-session, skills-based, manualized resilience education program delivered via video coaching by trained English or Spanish speaking PRISM coaches.<

Date: 2023-09-08

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Status: Completed

Condition: Malignant Pleural Mesothelioma

Interventions: At baseline (before any treatment is administered) and at three points after treatment (1, 3, and 6 months).
A breath sample from each patient wi

Date: 2023-09-08

Medicare Anti-A? mAb Coverage With Evidence Development (CED) Study

Status: Completed

Condition: Mild Alzheimer's Disease

Interventions: FDA approved monoclonal antibodies directed against amyloid for the treatment of AD

Date: 2023-09-08

Transnasal Induction of Normothermia for Neurogenic Fever

Status: Completed

Condition: Stroke, Ischemic

Interventions: Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 24 hours

Date: 2023-09-08